Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy

Introduction: Ki67 value and its variation before and after neoadjuvant chemotherapy are commonly tested in relation to breast cancer patient prognosis. This study aims to quantify the extent of changes in Ki67 proliferation pre- and post-neoadjuvant chemotherapy, confirm an optimal cut-off point, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Shirong, Fu, Xin, Xu, Shouping, Qiu, Pengfei, Lv, Zhidong, Xu, Yingying, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722379/
https://www.ncbi.nlm.nih.gov/pubmed/34987312
http://dx.doi.org/10.3389/pore.2021.1609972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722379/
https://www.ncbi.nlm.nih.gov/pubmed/34987312
http://dx.doi.org/10.3389/pore.2021.1609972

Ejemplares similares